.png)
Design Cells/iStock via Getty Images
- Incyte (NASDAQ:INCY) said on Thursday that the U.S. FDA has given expanded approval to Zynyz in combination with chemotherapy and as a monotherapy for treatment of adults with metastatic anal cancer.
- The agency gave an approval to Incyte’s drug Zynyz
English (US) ·